Drugs & Therapy Perspectives

, Volume 28, Issue 10, pp 24–26 | Cite as

Improve adherence to guideline medications in older patients who have undergone coronary bypass surgery

Practical Issues and Updates

Older patients who have undergone coronary artery bypass grafting surgery may be under-prescribed appropriate guideline medications or may be non-adherent to treatment, leading to increases in morbidity, mortality and healthcare costs. A number of interventions may improve adherence to medication guidelines in the hospital, post-discharge and over the longer term.

Specific challenges in the elderly

Coronary artery bypass grafting (CABG) surgery is often performed in elderly patients, but non-adherence to post-CABG guideline medications is a common and serious clinical concern in this age group.[ 1] Although non-adherence may occur in all age groups, unique challenges that may limit the success of surgical and medical treatments in elderly patients include:[ 2]
  • difficulties in hearing and comprehending physician instructions;

  • problems in remembering discussions about treatments because of cognitive impairment;

  • poor management of the administration of multiple medications with complex...


Coronary Artery Bypass Grafting Acute Myocardial Infarction Medication Adherence Home Blood Pressure Coronary Artery Bypass Grafting Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sengstock D, Vaitkevicius P, Salama A, et al. Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: strategies to improve adherence. Drugs Aging 2012; 29 (2): 93–103PubMedCrossRefGoogle Scholar
  2. 2.
    Banning M. A review of interventions used to improve adherence to medication in older people. Int J Nurs Stud 2009 Nov; 46 (11): 1505–5PubMedCrossRefGoogle Scholar
  3. 3.
    Rouleau JL, Warnica WJ, Baillot R, et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008 Jan 1; 117 (1): 24–31PubMedCrossRefGoogle Scholar
  4. 4.
    Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy: results of a Veterans Administration cooperative study. Circulation 1989 Nov; 80 (5): 1190–7PubMedCrossRefGoogle Scholar
  5. 5.
    Crystal E, Connolly SJ, Sleik K, et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002 Jul 2; 106 (1): 75–80PubMedCrossRefGoogle Scholar
  6. 6.
    The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997 Jan 16; 336 (3): 153–62CrossRefGoogle Scholar
  7. 7.
    Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 Jan 20; 342 (3): 145–53PubMedCrossRefGoogle Scholar
  8. 8.
    Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003 Sep 6; 362 (9386): 782–8PubMedCrossRefGoogle Scholar
  9. 9.
    Braunwald E, Domanski MJ, Fowler SE, et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004 Nov 11; 351 (20): 2058–68PubMedCrossRefGoogle Scholar
  10. 10.
    Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994 Jan 8; 308 (6921): 81–106CrossRefGoogle Scholar
  11. 11.
    Pedersen TR. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med 1985 Oct 24; 313 (17): 1055–8PubMedCrossRefGoogle Scholar
  12. 12.
    Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002 Nov 23; 360 (9346): 1623–30PubMedCrossRefGoogle Scholar
  13. 13.
    Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004 Oct 5; 110 (14): e340–437PubMedGoogle Scholar
  14. 14.
    Foody JM, Ferdinand FD, Galusha D, et al. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation 2003 Sep 9; 108 Suppl. 1: II24–8PubMedGoogle Scholar
  15. 15.
    Fonarow GC, Abraham WT, Albert NM, et al. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2007 Jan; 153 (1): 82.e1–11CrossRefGoogle Scholar
  16. 16.
    Kjellgren KI, Ahlner J, Saljo R. Taking antihypertensive medication: controlling or co-operating with patients? Int J Cardiol 1995 Jan 6; 47 (3): 257–68PubMedCrossRefGoogle Scholar
  17. 17.
    Steinman MA, Hanlon JT. Managing medications in clinically complex elders: ‘there’s got to be a happy medium’. JAMA 2010 Oct 13; 304 (14): 1592–601PubMedCrossRefGoogle Scholar
  18. 18.
    Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med 2007 Sep; 4 (9): e283PubMedCrossRefGoogle Scholar
  19. 19.
    Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006 Dec 6; 296 (21): 2563–71PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2012

Personalised recommendations